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Tuning the relaxation rates of dual-mode T1/T2
nanoparticle contrast agents: a study into the ideal
system†
Natasha A. Keasberry,a Manuel Bañobre-López,b Christopher Wood,a
Graeme. J. Stasiuk,a,c Juan Gallo*a,b,d and Nicholas. J. Long*a,d
Magnetic resonance imaging (MRI) is an excellent imaging modality. However the low sensitivity of the
technique poses a challenge to achieving an accurate image of function at the molecular level. To over-
come this, contrast agents are used; typically gadolinium based agents for T1 weighted imaging, or iron
oxide based agents for T2 imaging. Traditionally, only one imaging mode is used per diagnosis although
several physiological situations are known to interfere with the signal induced by the contrast agents in
each individual imaging mode acquisition. Recently, the combination of both T1 and T2 imaging capabili-
ties into a single platform has emerged as a tool to reduce uncertainties in MR image analysis. To date,
contradicting reports on the effect on the contrast of the coupling of a T1 and T2 agent have hampered
the application of these specialised probes. Herein, we present a systematic experimental study on a
range of gadolinium-labelled magnetite nanoparticles envisioned to bring some light into the mechanism
of interaction between T1 and T2 components, and advance towards the design of efficient (dual) T1 and
T2 MRI probes. Unexpected behaviours observed in some of the constructs will be discussed. In this
study, we demonstrate that the relaxivity of such multimodal probes can be rationally tuned to obtain
unmatched potentials in MR imaging, exemplified by preparation of the magnetite-based nanoparticle
with the highest T2 relaxivity described to date.
Introduction
MRI is a powerful technique perfectly suited for biological
imaging.1,2 Properties like non-invasiveness, high penetration,
high spatial resolution and absence of ionising radiations,2
make it one of the first choices not only for human clinical
diagnosis, but also for the monitoring of the progression of
diseases/treatments, and for drug design. MRI images water
protons, measuring the relaxation time of their nuclear mag-
netic spins once they have been excited with a radio-frequency
pulse under a static magnetic field.3 The contrast in MR
images arises from the different chemical environment of
these water protons, which induces differences in the water
proton relaxation times (T ). This relaxation time can be greatly
affected by the presence of paramagnetic or superparamag-
netic compounds in the surroundings of the water molecules,
leading to an enhanced contrast on the MR images. There are
two major MRI modalities in use in hospitals when it comes to
the use of contrast agents; T1- and T2-weighted imaging. Gado-
linium-containing T1 contrast agents are the preferred contrast
agent in the clinic as the enhanced signal produced is more
favourable and easier to distinguish (although adipose tissue
is a well-known interference).4 T2 agents such as iron oxide
nanoparticles (IONPs), on the other hand produce a decrease
in signal intensity which can be misinterpreted as bleeding,
calcification or other abnomalies.5,6 Nanoparticles are a versa-
tile platform to which targeting molecules and drugs can be
coupled.7,8 Thus, having a single multifunctional probe inte-
grating both T1 and T2 contrast capabilities can overcome the
drawbacks of both MRI modalities, with compatible T1 and T2
acquisitions, allowing for artefacts to be reduced and diagnos-
tics to be doubly verified.
The earliest example of dual contrast T1/T2 MR imaging
was carried out by Weissleder et al. to image liver tumours
in rats. When Gd-DTPA and ferrite nanoparticles were
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co-administered, an enhanced tumour signal from the Gd-
DTPA was observed while the liver showed a negative signal
intensity from the accumulation of ferrite.9 Their results
showed an increase in r1 but no effect on r2 when both agents
were present at the same time. The same effect was observed
when the contrast agents were administered sequentially in
humans, in studies carried out by Semelka et al. and Kubaska
et al.10,11 Theoretically, integration of the T1 and T2 contrast as
a single entity as opposed to having them separately, would
result in T1 spin alignment in the same direction as the mag-
netic field induced by the T2 material, enhancing the T1 effect
while maintaining the T2 signal.
4,12 This theory was in part
confirmed by experimental evidence from Gao et al.12 Gd2O3-
embedded Fe3O4 nanoparticles (GdIO) were synthesised and
presented a synergistic enhancement of r1 and r2. The GdIO
showed higher r2 than Fe3O4 of similar size, as well as higher
r1 than Gd2O3 of similar size. In addition to this, the Gd2O3
nanoparticles showed no enhanced T2 contrast, while Fe3O4
nanoparticles showed limited enhanced T1 contrast. Other in-
organic hybrid systems combining T1 and T2 nanoparticles
such as those synthesised by Im et al.13 (Fe3O4/MnO) and Kim
et al.14 (Gd-doped iron oxide nanoparticles) have also shown
enhanced T1 contrast while retaining the T2 effects.
Although inorganic nanoparticle hybrids have shown some
promising results, simple conjugation of a paramagnetic
chelate to the surface of iron oxide nanoparticles is an even
more attractive method to produce dual-mode contrast agents
according to the reports published so far.15–18 The theoretical
assumption is that these simpler combined agents will present
an enhanced r1 without the r2 being significantly affected.
Actual results however, are much more complex. Yang et al.15
and Bae et al.16 showed independently with different T1/T2
systems, that r2 strongly decreases when iron oxide nano-
particles are conjugated to Gd chelates, accompanied by an
enhancement in the r1. Choi et al.
17 also observed the same
trend with a possible dependence on the distance between the
Gd and the magnetic core. Finally, Huang et al.18 showed
the opposite trend where both r1 and r2 increased with Gd
concentration when the T1 and T2 moieties were coupled.
In all these cases, r1 increases when Gd is incorporated.
However, the r2 trends are not consistent between different
publications/systems.
These contradicting results demonstrate that further
studies are required to understand the relationship between
the final relaxation rates and the design and structure of the
T1/T2 probes. Thus, in this research, a systematic series of iron
oxide nanoparticles functionalised with Gd chelates were pre-
pared to better understand the effect of this interaction on
the final relaxivity of the system, as well as to search for the
ideal (dual) MRI probe design. A rational screening of
different parameters arising from the combination of these T1
and T2 moieties was performed i.e. nature of the organic
coating of the magnetic nanoparticles, distance between
the magnetic and paramagnetic components, magnetic pro-
perties, and nature and presentation of the paramagnetic
component.
Materials and methods
General
All reagents except DOTA (1,4,7,10-tetraazacyclododecane-
1,4,7,10-tetraacetic acid) (CheMatech) and PEG molecules
(Quanta Biodesign and Iris Biotech) were purchased from
Sigma-Aldrich and used as supplied. 6 nm Fe3O4 nanoparticles
were prepared according to Sun et al.19 by thermal decompo-
sition. Fourier transform infrared (FT-IR) spectra were
recorded using a Perkin Elmer Spectra 100 FT-IR Spectrometer.
UV-Vis spectra were recorded using a Perkin Elmer Lambda 25
UV/Vis Spectrometer. A JEOL 2010 transmission electron
microscope working at 200 keV was used to image the nano-
particles. Hydrodynamic size studies were performed either/
both on a Malvern Zetasizer Nano ZS instrument or a Perkin
Elmer Delsa NanoS. T1 and T2 relaxation times were measured
with a Minispec mq60 relaxometer working at 1.47 T and
selected samples were measured also in a DRX400 Bruker
NMR spectroscope at 9.4 T. Imaging was performed in a 3 T
horizontal bore MR Solutions Benchtop MRI system (Guild-
ford, UK) equipped with 48 G cm−1 actively-shielded gradients.
For imaging the sample, a 56 mm diameter quadrature bird-
cage coil was used in transmit/receive mode.
Ligand exchange on 6 nm Fe3O4 nanoparticles with
11-aminoundecanoic acid
Prior to the ligand exchange, 2 mL (3 mg mL−1 Fe) of the
original nanoparticle solution were washed extensively three
times with methanol, and twice with each ethanol and
acetone (5 mL each), followed by centrifugation for 5 minutes
at 17 000g. Finally the sample was resuspended in THF (4 mL)
and mixed with water (4 mL) containing 11-aminoundecanoic
acid (50 mg, 0.24 mmol). This solution was stirred for 48 h
and then was directly centrifuged for 5 minutes at 17 000g, the
supernatant discarded and the pellet washed in the same way
with a 1 : 1 mixture of THF : water (5 mL total). Finally the
pellet was resuspended in water (2 mL) and stored in the
fridge until further use.
Ligand exchange on 6 nm Fe3O4 nanoparticles with alendronic
acid
Bulk oleic acid-capped nanoparticles (2 mL, 3 mg mL−1 Fe)
were precipitated out of hexane and resuspended in THF
(2 mL). Sodium alendronate trihydrate (50 mg) was dissolved
in water (5 mL) and the pH adjusted to 9 with 1 M KOH. The
THF solution of the nanoparticles was added to the ligand
solution, and stirred for 2 days at room temperature. Then, the
stirrer bar was removed and the nanoparticles isolated with a
magnet. The supernatant was decanted and the black solid
suspended in water (2 mL). Acetone (10 mL) was added to
wash out any remaining ligand and this was repeated a further
two times. Finally, the nanoparticles were resuspended in
water (5 mL) and the pH checked to ensure it was at pH 8
(adjusted accordingly with KOH solution).
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Fmoc-PEGx-CO2H coupling
Bifunctional carboxylic/Fmoc PEG molecules of different
molecular weights were used for the fuctionalisation of
the nanoparticles. In general, Fe3O4 nanoparticles (1 mg,
1.6 × 10−9 mol) were mixed in DMSO (2 mL) with PEG
(1.6 × 10−6 mol), and EDC (10 mg, excess) was added to the
solution. The reaction was allowed to take place overnight.
Next day the sample was centrifuged (17 000g, 5 minutes), the
supernatant discarded, and the pellet washed three times
with water in the same way. Then, to deprotect the amine, the
pellet was resuspended with ultrasonication in a 80/20 mixture
of DMF/piperidine (5 mL) and shaken for 15 min. After cen-
trifugation under the same conditions, this deprotection
step was repeated two more times and finally the pellet
was resuspended in water and stored in the fridge until
further use.
DOTA coupling
DOTA (194.1 μg, 4.8 × 10−7 mol) was activated in water
with EDC (100.8 μg, 5.28 × 10−7 mol) and NHS (93.23 μg, 8.1 ×
10−7 mol). After 90 minutes the product of this reaction
was mixed with PEG functionalised nanoparticles (1 mg, 1.6 ×
10−9 mol), and stirred overnight. To purify the final product,
acetone (1 mL) was added and the particles were centrifuged
(17 000g, 5 minutes). The supernatant was kept to calculate the
yield of the reaction and the pellet was washed two more times
in the same way (acetone addition followed by centrifugation).
Finally the nanoparticles were resuspended in water (2 mL),
aliquoted, and stored in the freezer until further use.
The yield of the DOTA coupling was measured by incubat-
ing the washings from the coupling reaction with a known
amount of GdCl3 overnight and subsequently measuring the
amount of free non-chelated Gd(III) using xylenol orange and
UV-Vis spectroscopy (ESI, S3†).20
Gd(III) chelation
In a model reaction, DOTA-functionalised nanoparticles (1.3 ×
10−9 mol) were mixed in acetate buffer (2 mL, 0.2 M, pH 6.5)
with a solution of GdCl3·6H2O (12.36 μg, 7.86 × 10−8 mol). The
mixture was shaken overnight. After this time, the solution
was destabilised by the addition of acetone (1 mL) and centri-
fuged for 5 minutes at 17 000g. The supernatant was dis-
carded, and the pellet was resuspended in water (2 mL) and
stored until further use.
The amount of Gd(III) was calculated from three indepen-
dent ICP-OES measurements.
Relaxivity measurements
Four aqueous dilutions of different nanoparticle concen-
trations (between 0 and 0.6 mM Fe and 0 and 0.02 mM Gd,
when present) were prepared of each sample. For measure-
ments in the Minispec (1.47 T) 200 μL of samples were pre-
pared in relaxometer tubes in water. For measurements at
9.4 T, the samples (600 μL) were placed in standard NMR
tubes along with a capillary tube filled with deuterated water
to facilitate the locking. Standard CPMG and saturation
recovery sequences were used for T2 and T1 measurements
respectively. All experiments were performed at 37 °C. The
relaxivity constants (both r1 and r2) were calculated as the
slope of the curve fitting T1
−1 or T2
−1 values versus the metal of
interest concentration in mM.
TEM sample preparation
The nanoparticles were deposited from their solutions (7 µL)
onto holey carbon TEM grids with 300 mesh (Agar Scientific,
UK) and dried at room temperature before the imaging.
Magnetic measurements
The magnetic properties of the hybrid systems were measured
in a superconducting quantum interference device (SQUID)
from Quantum Design. For the sample preparation, 20 µL of
the solution sample were introduced in a PTFE sample holder
also provided by Quantum Design. Then, the solvent was evap-
orated under vacuum until the sample was perfectly dry. After-
wards, the sample holder was closed and placed in a brass
row. Magnetization curves as a function of the magnetic field
(hysteresis loops) were measured at room temperature and 2 K
under an applied magnetic field up to 2 T.
MR imaging
For the phantom measurements, the samples at different con-
centrations (between 25 and 100 µM in Fe/Gd) were dissolved
in 200 µL of water in 300 µL tubes. All MR images of the
phantoms were acquired with an image matrix 256 × 252, FOV
60 × 60 mm, 3 slices with a slice thickness of 1 mm and 1 mm
slice gap. For T2-weighted imaging a fast spin echo (FSE)
sequence with the following parameters was used: TE = 11 ms,
TR = 12 000 ms, NA = 32. For T1-weighted imaging a fast spin
echo based (FSE) sequence with the following parameters was
used: TE = 11 ms, TR = 720 ms, NA = 32.
Results
The most straightforward idea to combine T2 and T1 effects
into a single probe is the direct coupling of both species cur-
rently approved for human diagnostics, namely Gd(III) chelates
and iron oxide nanoparticles. This strategy, in principle
simpler than inorganic approaches,12,17,21,22 seems also more
interesting as, according to previous reports,15,16,18,23 unex-
pected effects arising from this coupling can be observed in
the final performance of the contrast agents. In this sense,
this approach allows us to finely tune several design para-
meters that affect the relaxivity properties of the nanoprobes,
independently from each other, and so establish a cause-effect
relationship on their relaxivity properties and their suitability
as T1 and/or T2 MRI probes. In our search for the ideal MRI
contrast agent we decided to systematically explore this
approach through the evaluation of fully characterised iron
oxide nanoparticles functionalised with DOTA-Gd(III) mole-
cules. This study was divided into several sample subsets to
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evaluate the effect of different parameters into the final relaxiv-
ity performance (Scheme 1). First, different molecules were
studied as protecting/stabilising ligands on the nanoparticles
(set 1). Once this first step was optimised, different T1 moieties
were evaluated (set 2), and finally, the effect of the distance
between the T1 and T2 components was also examined (set 3).
To evaluate the potential interactions between T2 and T1
moieties in a single probe, iron oxide magnetic nanoparticles
were covalently functionalised with Gd chelates. A thermal
decomposition protocol was adopted for the preparation of
iron oxide nanoparticles as this methodology provides highly
crystalline products and the reaction conditions can be closely
controlled to obtain samples with different particle size and
narrow size distribution.24 Highly monodisperse magnetite
(Fe3O4) nanoparticles of 6 nm of particle size were prepared
using iron acetylacetonate as starting material, as shown by
TEM (Fig. 1A, ESI, Fig. S1†).19 Both the phase formation and
high crystallinity of the nanoparticles were evidenced by
selected area electron diffraction (SAED) and X-ray diffraction
(XRD). The presence of secondary phases due to impurities
was completely discarded as no extra reflection peaks were
identified (Fig. 1).
As-prepared nanoparticles were only soluble in apolar sol-
vents and thus not compatible with biological applications.
A ligand exchange strategy was chosen to transfer the nano-
particles from organic to aqueous solution using more suitable
bifunctional water soluble molecules. For this purpose, and
to investigate the effect of ligands protecting/stabilising the
nanoparticles on the final relaxivity, the nanoparticle surface
was first functionalised with one of the following ligands
(Scheme 2): 11-aminoundecanoic acid (AUA, a classic bifunc-
tional carboxylic/amine small molecule, NP1), O-(2-phospho-
noethyl)-O′-(2-aminoethyl)pentaethylene glycol (P-PEG6-NH2, a
bifunctional phosphate/amine ligand, NP2), or alendronic
acid, (ALA, a bifunctional, bisphosphonate/amine molecule,
NP3). Phophates/bisphosphonates have not been explored as
much as carboxylates as iron oxide ligands, but they have also
been shown to render water soluble nanoparticles with good
stability and magnetic properties.6,24–27 To evaluate the
efficiency of the ligand exchange, the nanoparticles were
characterised by infrared spectroscopy, (ESI, Fig. S2 and S3†).
Functional groups with a strong stretching frequency, such as
C–O in the carboxylic group (around 1500 cm−1), and the phos-
phonate resonance (strong PvO stretch around 1100 cm−1),
Scheme 1 Overview of the different modifications to the T1/T2 systems, with the particular modification of each set highlighted by the dashed
lines.
Fig. 1 A, TEM micrograph of as-prepared Fe3O4 nanoparticles (oleic acid capped). B, SAED showing Fe3O4 lattice ring patterns. C, XRD diffracto-
gram with indexed peak positions. Scale bar, 100 nm.
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can be used to follow the nanoparticle surface
functionalization.
The transversal relaxivity value, r2, for NP3 (360.0 mM
−1 s−1
at 1.47 T and 37 °C, Table 1) was found to be higher than most
of the other iron oxide nanoparticles (IONPs) coated with car-
boxylate-based ligands28–30 including NP1 (153.8 mM−1 s−1). It
was found to be also higher than the r2 of phosphate protected
particles, NP2 (178.7 mM−1 s−1). On the basis of the quantum
mechanical outer sphere theory, the T2 relaxivity is highly
dependent, among other factors, on the saturation magnetisa-
tion of the nanoparticles.31 The preparation method of the
nanoparticles, together with the nature of the coating ligands
(depending on the functional group anchoring the ligand to
the particle) have been found to greatly affect the saturation
magnetisation, resulting in differing relaxation rates. Surface
effects drastically increase when the particle size decreases. In
the particular case of magnetite, core–shell structures are gen-
erally assumed in which the bulk spin arrangement of the core
contrasts with the spin canting effects present in the atomic
surface layers, which are supposed to be the reason of a
decreasing saturation magnetisation as the particle size is
reduced. This phenomena has been shown for both carboxy-
late- and phosphate/phosphonate-coated nanoparticles.32
However, advances in chemical surface functionalization strat-
egies have re-opened discussions about the effect of coating
agents on the magnetic ‘dead’ outer layer in magnetic nano-
particles.33,34 In this sense, although previous works reported
atomic disorder and spin-glass behaviour at the surface of
magnetite nanoparticles,32,35 more recent studies show evi-
dence of a highly crystallized nanoparticle surface with long
range atomic order induced by the effect of the anchoring
groups of coating ligands.36,37 Therefore, different anchoring
Scheme 2 Structures of the series of nanoparticles used in this study.
Table 1 Summary of the relaxivity results obtained in this study. All r values were measured at 1.47 T and 37 °C in water and are expressed in
mM−1 s−1
Modification NP r2 ([Fe]) r1 ([Fe + Gd]) r1 ([Gd])
Ligand NP1 153.8 ± 25.4 15.0 ± 2.5a —
NP2 178.7 ± 15.2 3.9 ± 1.2a —
NP3 360.0 ± 30.5 29.4 ± 3.2a —
Initial functionalization NP3 360.0 ± 30.5 29.4 ± 3.2a —
NP4 358.6 ± 28.3 17.3 ± 2.4a —
Metal NP4 358.6 ± 28.3 17.3 ± 2.4 —
NP5 836.7 ± 51.1 31.6 ± 2.6 451.5 ± 34.4
NP6 324.5 ± 24.6 14.2 ± 2.1 248.6 ± 20.0b
NP7 209.9 ± 19.9 15.8 ± 2.6 192.7 ± 19.8c
Distance NP-Gd NP5 836.7 ± 51.1 31.6 ± 2.6 451.5 ± 34.4
NP8 272.7 ± 16.5 7.0 ± 1.7 191.0 ± 23.6
NP9 212.7 ± 21.7 6.1 ± 2.1 404.0 ± 29.8
PEGylation NP3 360.0 29.4 ± 3.2a —
NP10 197.6 4.1 ± 1.1a —
NP11 530.8 19.1 ± 2.8a —
a r1 values calculated with respect to Fe concentration.
b r1 value calculated with respect to Mn concentration.
c r1 value calculated with respect to
Zn concentration.
Nanoscale Paper
This journal is © The Royal Society of Chemistry 2015 Nanoscale, 2015, 7, 16119–16128 | 16123
O
pe
n 
A
cc
es
s 
A
rt
ic
le
. P
ub
lis
he
d 
on
 0
9 
Se
pt
em
be
r 
20
15
. D
ow
nl
oa
de
d 
on
 6
/1
/2
02
0 
4:
54
:3
1 
PM
. 
 T
hi
s 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
L
ic
en
ce
.
View Article Online
functional groups affect differently the net saturation magneti-
sation via spin disorder at the nanoparticle surface.32 Spin
canting is less significant in phosphate-based ligands than in
carboxylate-based ones,32 and thus phosphate-coated nano-
particles were expected to present a higher magnetisation and
therefore higher relaxation rates (Fig. 2 and ESI, Fig. S4†).
Additionally, the use of high temperature thermal decompo-
sition synthesis technology is known to lead to IONPs with
superior crystallinity, which is also correlated to higher nano-
particle magnetisation.38,39 These two factors, the lack of spin
canting, and the high crystallinity of the core, justify the excep-
tionally high relaxation rate of NP3, and its better performance
when compared to NP1 and NP2.
The next step of this study was to optimise the nature of the
paramagnetic moiety. Gd(III) is the most effective paramagnetic
metal for use as a T1 contrast agent due to its seven unpaired
electrons and suitable magnetic moment.40 The main concern
with Gd(III) comes from its toxicity. Other paramagnetic ions,
such as Mn(II) (five unpaired electrons in high spin configur-
ation) have also been used as T1 contrast agents to some
extent. Zn(II), a diamagnetic ion was used as a blank in these
studies as no magnetic effects are expected from it. In the
clinic, Gd(III) has to be used in combination with an appropri-
ate chelator to avoid its interaction with biological processes.41
The thermodynamic stability and dissociation constant of the
resulting complexes are crucial parameters that will determine
the level of toxicity at the final application. The most widely
used of these chelates is DOTA (1,4,7,10-tetraazacyclodode-
cane-1,4,7,10-tetraacetic acid) due to its biocompatibility and
good stability,42 and therefore, it was selected as the chelator
of choice for this study. The conjugation of DOTA to the nano-
particles was carried out stoichiometrically, using standard
peptidic chemistry to couple one of the carboxylic acids on the
chelate to one of the amines on the surface of the nano-
particles. EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodi-
imide) and NHS (N-hydroxysuccinimide) were used as
coupling reagents. To determine the stoichiometry of reagents
required, the density of ligands on the nanoparticles was first
determined (ESI, Fig. S5, Table S1†) by TGA to be 1.02 ligands
per nm2. The yield of the DOTA coupling reactions was calcu-
lated measuring the amount of non-reacted chelate through
an indirect colorimetric method (ESI, Fig. S6 and S7†).20 DOTA
coupling yields were >80%. Finally, Gd(III) (or Mn(II)/Zn(II)) was
incorporated into the nanoparticles via an overnight incu-
bation with GdCl3 (MnCl2/ZnCl2) salts in pH 6.5 acetate buffer.
Any unbound Gd(III), (Mn(II) or Zn(II)) was removed by centrifu-
gation. The yield of Gd(III), (Mn(II), Zn(II)) incorporation was
calculated (from ICP measurements) to be above 95% (with
respect to DOTA) for all the samples.
The incorporation of a paramagnetic moiety on the nano-
particles brings with it a conceptual problem in the calculation
of the relaxivity rates. The calculation of the r1/2 of a contrast
agent is achieved by plotting the inverse of the relaxation time
versus the concentration of the element responsible for the
change in the relaxation. While Gd(III) is known to have a negli-
gible effect on the transversal relaxation of protons, iron oxide
nanoparticles present a significant effect on the longitudinal
relaxation and therefore could/should be considered for the
calculation of r1. In these nanoparticulate systems, the concen-
tration of Fe is around one order of magnitude higher than
that of Gd, which means that when considered together for
the calculation of the relaxivity, only a small difference is
observed from Gd contribution. This is why some authors
decide to obviate Fe and calculate r1 only in respect to the con-
centration of Gd.12,22
Prior to comparing the effects of paramagnetic elements on
the global relaxivity, r1/2 of NP3 were compared to those of
NP4. As expected, there were no significant changes on the r2
before and after the coupling of DOTA (360.0 vs. 358.6 mM−1
s−1). On the other hand, when comparing the longitudinal
relaxivity, a significant decrease was observed (29.4 vs.
17.3 mM−1 s−1). Unlike T2 effects where no contact is needed
between the proton and the magnetic component (spin–spin
relaxation) to effectively modify the longitudinal relaxation, a
T1 relaxation mechanism implies a direct contact between the
water molecules and the contrast agent. Thus, any modifi-
cation in the outer shell of the nanoparticles has the potential
to change the r1.
The introduction of paramagnetic species in the probe is
assumed to have a bigger impact on the r1. When considering
only the newly introduced element, the obtained r1 values for
NP5, 6 and 7 followed the expected trend; the most paramag-
Fig. 2 Magnetic characterisation of the NPs. A, Room temperature magnetic curves as a function of the applied magnetic field for NPs with
different ligands (NP1, NP2, NP3). B, Room temperature magnetic curves as a function of the applied magnetic field for NPs with different metals
(NP3, NP5, NP7). C, Room temperature magnetic curves as a function of the applied magnetic field for NPs with different functionalisations (NP3,
NP5, NP8, NP9, NP10 and NP11)). Results not corrected for diamagnetic component from the sample holder.
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netic ion, Gd(III) presented the highest value, followed by
Mn(II) (weaker paramagnetic), and then by Zn(II) (451.5 >
248.6 > 192.7 mM−1 s−1). DOTA-Gd(III) on its own presents a
much lower relaxation rate of around 4 mM−1 s−1 at 1.47 T.
This difference in relaxivity (from 31.6 to 4 mM−1 s−1) results
from the combination of a multimeric effect on the nano-
particle and changes in the tumbling rate at this field. When
r1 values were calculated considering the combined amount of
Fe + Gd (Mn/Zn), the results were not that easy to explain. Gd
also produced an increase in the r1 (31.6 vs. 17.3 mM
−1 s−1).
Surprisingly, both Mn and Zn brought a non-significant
decrease in the relaxivity (14.2 and 15.8 vs. 17.3 mM−1 s−1).
Due to the low X/Fe ratio, only a significant increase is
observed in the case of X = Gd when the sum of Fe + X is taken
as parameter of normalization, because of Gd strong effect
(7 unpaired electrons) on T1. In the case of Zn, where no
magnetic effects are foreseen, the relaxivity value showed no
change compared NP4. NP6 (Mn2+) does not show any signifi-
cant difference compared to NP4, the behaviour being very
similar to Zn. Mn(H2DOTA) is 6 coordinate with a distorted
octahedral geometry (through solid state crystal structure). In
solution however, the uncoordinated carboxylates are expected
to ionise (due to low pKa values).
43 Deprotonation of uncoordi-
nated pendant arms could lead to binding of the pendant arm
to the metal centre, resulting in a net increase in the metal
coordination number. Mn2+ ion has a maximum coordination
number of 8, and when this deprotonation and subsequent
binding of the pendant arm occurs in solution, the Mn2+ for
these particles would reach coordinative saturation and only
the outer sphere water exchange will contribute to relaxation
rates.43
A similar theme is found when analysing the r2 values for
the same series of particles. Similarly to r1 (Fe + Gd) values, r2
is anomalously enhanced by the incorporation of Gd(III) (836.7
vs. 358.6 mM−1 s−1), in agreement with the higher saturation
magnetisation of the hysteresis loop (Fig. 2 and ESI, Fig. S4†).
To the best of our knowledge, this r2 value is the highest
reported to date for magnetite nanoparticles of 6 nm size. To
double-check this extraordinary value, the r2 of this nano-
particle was also measured at 9.4 T. The value obtained, 414.61
± 35 mM−1 s−1, is still the highest relaxivity reported to date
for this kind of particle at high field (the relaxivity decreases
strongly at high fields). MR images acquired at 3 T of phan-
toms of this samples at different concentrations, further con-
firmed the outstanding properties of NP5, both in T2-weighted
and T1-weighted mode (ESI, Fig. S8 and S9†). Under the
imaging conditions used (see Materials and methods section),
NP5 produced a clear change in the contrast in T2-weighted
mode at any of the concentrations tested. NP3 also produced a
significant change at 100 and 50 µM, while the nanoparticle
with the classic carboxylate ligand, NP1, did not change the
contrast even at the highest concentration tested (100 µM). In
T1-weighted mode, again only NP5 produced a clear signal. In
this case the strongest signal change was observed, as
expected, from the commercial agent Dotarem® at a concen-
tration of 100 µM in Gd.
Mn and Zn incorporation brought a decrease in the r2,
which was statistically significant in the case of Zn. As
mentioned above, both a decrease and an increase in the r2
caused by the coupling of a paramagnetic moiety has been
reported before.15,16,18 In our system, only Gd shows an effect
on r2 which suggests that Mn
2+ paramagnetism is not strong
enough to produce a change in the relaxivity of the final probe.
In T1/T2 constructs, the increase in r2 has been attributed to an
alignment of the electronic spins of the paramagnetic ion by
the induced magnetic field generated by the superparamag-
netic particles.12
In a different set of experiments, the influence of the dis-
tance between the superparamagnetic and the paramagnetic
units was explored. In order to investigate this potential dis-
tance dependency, a bifunctional carboxy/amine polyethylene
glycol (PEG) spacer was included between DOTA and the
bisphosphonate molecule (ESI, Scheme S1†). Two different
PEG sizes were tested, a short PEG comprising 12 units
(600 Da, NP8), and a long PEG of 96 units (5000 Da, NP9). The
construction of the probes was achieved in three steps. First,
PEG molecules were coupled to the nanoparticles in water fol-
lowing standard peptidic chemistry. Then, the amine terminal
side of the PEGs was deprotected in DMF : piperidine (80 : 20),
and finally DOTA was coupled stoichiometrically using pepti-
dic chemistry again. To have a better control over the system,
these complex probes were fully characterised by TGA to deter-
mine the average number of PEG molecules per nanoparticles
(71 PEG600 and 57 PEG5000 per NP, ESI, Table S2†).
Relaxivity results for this set of samples showed a clear
dependency of the r2 with the distance. When the paramag-
netic and superparamagnetic components are close by, the
final r2 of the particles is greatly enhanced (NP4 358.6 vs. NP5
836.7 mM−1 s−1). From there, with increasing Mw of the PEG,
the r2 of the probes decreases to values below that of the origi-
nal particles (NP8 272.7 and NP9 212.7 mM−1 s−1). This r2 dis-
tance dependency has already been observed by other authors
in inorganic systems,17 and was simply attributed to a decrease
of the magnetic field generated by the superparamagnetic par-
ticles with the distance (1/r3, r being the distance from the par-
ticle). In our system, the hydrodynamic size also increases with
PEG size (NP5 31.87 nm, NP8 37.70 nm and NP9 40.70 nm,
ESI, Tables S3 and S4†). This decrease in r2 could then be the
consequence of a weaker magnetic coupling between the
superparamagnetic iron oxide nanoparticle and the paramag-
netic Gd ion as the PEG molecular weight increases.
r1 (Fe + Gd) values follow the same trend as those of r2 (NP4
17.3, NP5 31.6, NP8 7.0, NP9 6.1 mM−1 s−1), with an initial
increase when Gd is closest to the nanoparticles, followed by a
significant decrease as the distance between the two moieties
is increased. The presence of a PEG spacer may account for
part of this decrease as the tumbling rate of the chelates
coupled to these flexible molecules will be faster than that of
the chelates directly attached to the more rigid alendronic acid
(the longer the PEG, the faster the tumbling rate). Further-
more, a magnetic interaction between the superparamagnetic
magnetite core and the paramagnetic Gd complex at that
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minimal distance could be responsible for the observed r1
enhancement. As the length of the PEG chain becomes longer
and the packing of the PEG chains around the magnetic core
is more favoured, this magnetic interaction would disappear
and only the Gd ion would contribute primarily to the r1,
bringing a significant decrease. This is also supported by the
magnetic results (ESI, Fig. S4†). The hysteresis loops for the
samples NP4 and NP5 (minimum distance between Fe3O4 and
Gd) show the highest saturation magnetization, so that the
possibility of a magnetic interaction between the magnetic
core and the Gd complex must be considered. On the other
hand, the longer the PEG spacer, the lower the saturation mag-
netisation. Therefore, in addition to a longer separation dis-
tance, a lower intensity of the magnetic field coming from the
magnetite core, would justify for samples NP8 and NP9 a negli-
gible magnetic coupling with the Gd complex and the corres-
ponding significant decrease of r1 compared to NP5. When
only the concentration of Gd(III) is considered for the calcu-
lation of the longitudinal relaxivity, there is an initial strong
decrease in r1 from NP5 to NP8 (451.5 vs. 191.0 mM
−1 s−1) fol-
lowed by a recovery of the r1 from NP8 to NP9 (191.0 vs.
404.0 mM−1 s−1). These values are more difficult to rationalise
and require a more detailed study of these particles and the
intermediate functionalised probes. Comparison of the r2
values of NP3, NP10 and NP11 (360.0, 197.6 and 530.8 mM−1
s−1) give initially the same trend as the one observed when Gd
is present; there is an initial decrease in r2 with the short PEG
chain. The introduction of a longer PEG chain, surprisingly
increases the relaxivity of the probes. r1 values follow a similar
trend with a decrease with the short PEG and a partial recovery
of the r1 with the longer PEG. To try to explain these unex-
pected changes in MR performance, the conformation of the
PEG molecules on the surface of the particles was studied.
PEG molecules can adopt two different conformations on a
surface, brush (extended), or mushroom (coiled). The space
that each PEG molecule occupies on the surface of the nano-
particle (D) can be calculated and compared to the Flory
radius (Rf ) of that PEG. If Rf is bigger than D then the PEGs
adopt a mushroom conformation.44 Calculation of these para-
meters (ESI, Table S5†) showed that the most probable confor-
mation for both PEGs was brush, so the conformation does
not help to explain the differences in relaxivity. Although this
theory has been shown very helpful in many cases, for this par-
ticular application a more suitable approach that takes into
account the curvature of the particles might be needed to
explain effects such as those observed here. In our case the
coupling of a much heavier PEG molecule is only accompanied
by a modest increase in hydrodynamic size. This might
suggest an intermediate PEG conformation between brush and
mushroom not contemplated in planar models.
A detailed study of the M vs. H curves for samples NP3,
NP10 and NP11 shows a decrease of the saturation magnetisa-
tion as the PEG chain is introduced, compared to the situation
in which only alendronic acid is attached to the particle
surface (ESI, Fig. S4†). However, and in agreement with the
observed trend in relaxivity, the saturation magnetisation
recovers as the number of ethylene units in the PEG increases
(NP11). According to the outer sphere relaxation approach, an
increase of r2 from NP10 to NP11 would also be expected from
the observed partial recovery of the saturation magnetisation.
However, although the magnetic and relaxivity data are in
agreement, we believe that more detailed experiments need to
be conducted in order to assure that the observed relaxivity
values are directly coupled exclusively to the magnetic data
and no other factors i.e. the degree of freedom of the PEG
chains.
Conclusion
The low sensitivity of MRI requires the use of contrast agents,
especially in fields like oncology where detection of small fea-
tures (early detection of tumours) is crucial for patient survi-
val. Current contrast agents are far from ideal, with severe
limitations both in performance (particularly at high fields)
and ease of diagnosis. The combination of T1 and T2 imaging
capabilities into a single probe is one of the ways forward, at
least in respect to trustworthy diagnosis. This field of dual-
modal MRI agents is only in its early development and results
so far lack uniformity. Systematic studies such as this one are
required to evaluate the effect of the coupling of a paramag-
netic moiety to a superparamagnetic one. In this report,
several parameters involved in the design of these dual probes,
such as nature of the ligands, spacing between the two active
components, and nature of the paramagnetic element, have
been studied in detail. The importance of exerting close
control over some of these parameters has been highlighted by
this work. The distance between the two components is shown
to be key to maximise the r1/2 of the probes. A close proximity
between the paramagnetic and superparamagnetic moieties is
needed to maximise the potential of the probes. Also, Gd(III)
seems to be irreplaceable as the paramagnetic moiety, as
weaker paramagnetic ions like Mn2+, do not exert a sufficiently
strong influence on the final probe.
Even though other parameters (apart from r1 and r2) have
to be taken into consideration to evaluate the potential of a
probe as dual T1/T2 contrast agent (like the r2/r1 ratio), some of
the nanoparticles reported in this work are incredibly promis-
ing for diagnostic applications. For example, NP5 shows the
highest r2 reported to date for a 6 nm Fe3O4 based particle,
and NP11 presents a very high r2 together with the stealth pro-
perties coming from PEG functionalisation.
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